U.S. markets closed

Opthea Limited (OPT)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
7.42-0.18 (-2.37%)
At close: 4:00PM EDT
Sign in to post a message.
  • R
    Randy
    going down the tubes
  • Y
    Yahoo Finance Insights
    Opthea is up 9.42% to 7.20
  • Y
    Yahoo Finance Insights
    Opthea is down 14.94% to 6.41
  • M
    Mark
    Perfect short opportunity right here
  • P
    Paul
    Too bad OPT couldn't hold the gains...
    Sold some at $12, not enough.. lol
    The company at least got noticed, highest volume so far.
    Hopefully Big Pharma is poking around. Drugs going off patent in the near future.
  • M
    Mark
    Welcome new bagholders!! Oxygen masks are by the front door!
  • U
    UshaR
    OPT is PURE GARBGE
  • Y
    Yahoo Finance Insights
    Opthea is up 16.14% to 9.99
  • B
    BioWhisperer
    Paul, any word on DME results? past overdue by my expectations
  • P
    Paul
    "“The most striking new observation from Opthea’s recent clinical trial results was the apparent ability for OPT-302 to preserve vision,” Wilson’s Storey said in his research note.

    “Less than 1 per cent of patients treated with Opthea’s drug lost visual acuity, compared to 3-6 per cent of patients treated only with the current standard of care.”

    This helps build the case “for potential first line use” of Opthea’s treatment, he argues.
    https://stockhead.com.au/health/how-opthea-became-a-1-billion-stock-in-a-month-and-analysts-reckon-theres-still-more-to-come/
  • R
    RH
    Any research reports or excepts you can share?
  • R
    Randy
    what is the difference between CKDXY and CKDXF? which one do you buy or sell?
  • Y
    Yahoo Finance Insights
    Opthea is up 13.72% to 8.62
  • S
    Steve
    Sell before it goes back to $10.
  • P
    Paul
    DME study results soon. Crossing fingers.
    If successful, expect bid increase in stock price. Buyout probable.
  • P
    Paul
    DME study results to be release tomorrow in Australia.....6PM Central time US.
  • P
    Paul
    From the Hot Copper OPT board.....
    https://www.marketbeat.com/stocks/NASDAQ/OPT/

    OPT currently in "Quiet Period"

    WHAT PRICE TARGET HAVE ANALYSTS SET FOR OPT?
    3 Wall Street analysts have issued twelve-month price targets for Opthea's shares. Their forecasts range from $25.00 to $36.00. On average, they expect Opthea's share price to reach $31.33 in the next twelve months. This suggests a possible upside of 148.1% from the stock's current price.

    WHEN DOES OPTHEA'S QUIET PERIOD EXPIRE?
    Opthea's quiet period expires on Wednesday, November 25th. Opthea had issued 8,563,300 shares in its public offering on October 16th. The total size of the offering was $115,604,550 based on an initial share price of $13.50. During Opthea's quiet period, underwriters and any insiders involved in the IPO are prevented from issuing any research reports for the company because of SEC regulations. Following the end of the company's quiet period, it's expected that the brokerages that served as underwriters on the stock will initiate research coverage on the company.
  • U
    UshaR
    OPTN go to $10 today
  • M
    Mike
    $OPT https://youtu.be/IngHaybFt5gI think the best is yet to come. Great products for future medicine.